Company: MYSZ
Filing Date: 2025-03-27
Form Type: 10-K
Source: 0001641172-25-000990
Chunk: 785

Company: My Size, Inc.
Filing Date: 2025-03-27
Form: 10-K
Item: Item 7A
Chunk 785
---
 and third instalments certain revenue targets are met and subject
                                                                              further to certain downward post-closing adjustment. In February 2024, the amount of $700
                                                                              was fully paid to the former owners of Orgad net of a settlement amount of $275
                                                                              which was recorded as other income.
                                                                               
                                                                              Towards the end of 2023, the Company negotiated with the sellers to reduce the amounts owed to them, based on the fact that the actual
working capital was different from that reflected in the financial statements attached to the contract. The gaps were mainly from provision
for customer returns and value of the inventory. In a settlement agreement between the parties signed on February 2024, it was determined
that the sellers would waive an amount of $275.

    b.
    On
    November 3, 2023, the Company was notified, by the Nasdaq Listing Qualifications that the Company is not in compliance with the minimum
    bid price requirements set forth in Nasdaq Listing Rule 5550(a)(2) (the “Rule”) for continued listing on the Nasdaq.
    The Notification Letter provided that the Company had 180 calendar days, or until May 1, 2024, to regain compliance with the Rule.
    To regain compliance, the bid price of the Company’s common stock must have had a closing bid price of at least $1.00 per share
    for a minimum of 10 consecutive business days. On May 7, 2024, the Company received a letter from Nasdaq that, for the 10 consecutive
    business days from April 23, 2024 to May 6, 2024, the closing bid price of the Company’s common stock had been at $1.00 per
    share or greater. Accordingly, the Company has regained compliance with Nasdaq Listing Rule 5550(a)(2) and Nasdaq considers the prior
    bid price deficiency matter now closed.

NOTE
21 - EVENTS SUBSEQUENT TO THE BALANCE SHEET DATE

On January 21,
2025, the Company entered into an At The Market Offering Agreement (the “Offering Agreement”), with H.C. Wainwright & Co., LLC, pursuant to which the
Company may offer and sell, from time to time through Wainwright shares of the Company’s common stock having an aggregate
offering price of up to $4.1
million.

The Company is not obligated to make any sales
of the shares under the